Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 30 studies | 36% ± 16% | |
macrophage | 21 studies | 36% ± 20% | |
fibroblast | 21 studies | 32% ± 15% | |
plasma cell | 16 studies | 38% ± 20% | |
oligodendrocyte precursor cell | 16 studies | 43% ± 19% | |
astrocyte | 15 studies | 38% ± 16% | |
oligodendrocyte | 14 studies | 38% ± 14% | |
microglial cell | 14 studies | 46% ± 15% | |
smooth muscle cell | 12 studies | 28% ± 10% | |
glutamatergic neuron | 12 studies | 45% ± 25% | |
mast cell | 11 studies | 31% ± 12% | |
GABAergic neuron | 11 studies | 50% ± 22% | |
pericyte | 11 studies | 38% ± 18% | |
epithelial cell | 9 studies | 36% ± 15% | |
endothelial cell of lymphatic vessel | 8 studies | 30% ± 12% | |
myeloid cell | 8 studies | 39% ± 11% | |
adipocyte | 8 studies | 29% ± 11% | |
ciliated cell | 8 studies | 25% ± 10% | |
dendritic cell | 7 studies | 30% ± 10% | |
classical monocyte | 6 studies | 20% ± 5% | |
neuron | 6 studies | 47% ± 21% | |
interneuron | 6 studies | 61% ± 21% | |
endothelial cell of artery | 6 studies | 19% ± 4% | |
mesothelial cell | 6 studies | 39% ± 13% | |
Mueller cell | 6 studies | 39% ± 16% | |
basal cell | 6 studies | 28% ± 14% | |
type II pneumocyte | 6 studies | 33% ± 9% | |
monocyte | 6 studies | 42% ± 13% | |
IgG plasma cell | 5 studies | 23% ± 11% | |
amacrine cell | 5 studies | 32% ± 10% | |
B cell | 5 studies | 32% ± 11% | |
cardiac muscle cell | 5 studies | 50% ± 17% | |
respiratory goblet cell | 5 studies | 32% ± 15% | |
T cell | 5 studies | 29% ± 8% | |
connective tissue cell | 5 studies | 28% ± 13% | |
goblet cell | 5 studies | 33% ± 20% | |
club cell | 5 studies | 32% ± 13% | |
type I pneumocyte | 5 studies | 29% ± 10% | |
natural killer cell | 4 studies | 23% ± 7% | |
plasmablast | 4 studies | 29% ± 14% | |
granule cell | 4 studies | 41% ± 16% | |
CD4-positive, alpha-beta T cell | 4 studies | 21% ± 4% | |
CD8-positive, alpha-beta T cell | 4 studies | 17% ± 3% | |
lymphocyte | 4 studies | 38% ± 11% | |
retinal cone cell | 4 studies | 31% ± 12% | |
retinal rod cell | 4 studies | 29% ± 7% | |
endothelial cell of vascular tree | 4 studies | 31% ± 20% | |
hepatocyte | 4 studies | 59% ± 18% | |
myofibroblast cell | 4 studies | 27% ± 11% | |
alveolar macrophage | 4 studies | 48% ± 22% | |
capillary endothelial cell | 4 studies | 31% ± 10% | |
pancreatic A cell | 3 studies | 58% ± 19% | |
type B pancreatic cell | 3 studies | 49% ± 17% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 43% ± 2% | |
GABAergic interneuron | 3 studies | 50% ± 5% | |
glial cell | 3 studies | 31% ± 9% | |
progenitor cell | 3 studies | 34% ± 4% | |
retinal pigment epithelial cell | 3 studies | 37% ± 25% | |
mononuclear phagocyte | 3 studies | 32% ± 12% | |
vein endothelial cell | 3 studies | 37% ± 20% | |
retinal bipolar neuron | 3 studies | 33% ± 12% | |
GABAergic amacrine cell | 3 studies | 45% ± 13% | |
ON-bipolar cell | 3 studies | 38% ± 15% | |
glycinergic amacrine cell | 3 studies | 36% ± 7% | |
retina horizontal cell | 3 studies | 29% ± 9% | |
rod bipolar cell | 3 studies | 43% ± 19% | |
secretory cell | 3 studies | 20% ± 3% | |
IgA plasma cell | 3 studies | 39% ± 18% | |
abnormal cell | 3 studies | 35% ± 22% | |
neural progenitor cell | 3 studies | 38% ± 12% | |
ependymal cell | 3 studies | 38% ± 10% | |
enteroendocrine cell | 3 studies | 28% ± 7% | |
transit amplifying cell | 3 studies | 33% ± 23% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 6% | |
renal alpha-intercalated cell | 3 studies | 54% ± 27% | |
renal principal cell | 3 studies | 40% ± 18% | |
mural cell | 3 studies | 41% ± 10% | |
mucus secreting cell | 3 studies | 40% ± 20% | |
regulatory T cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 40% ± 21% | |
lung | 7 studies | 31% ± 9% | |
heart | 5 studies | 33% ± 13% | |
eye | 5 studies | 40% ± 15% | |
pancreas | 3 studies | 50% ± 15% | |
liver | 3 studies | 41% ± 21% | |
intestine | 3 studies | 20% ± 3% | |
adipose | 3 studies | 33% ± 5% | |
kidney | 3 studies | 33% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3315.67 | 1443 / 1445 | 100% | 41.01 | 183 / 183 |
lung | 100% | 5801.23 | 578 / 578 | 100% | 33.27 | 1151 / 1155 |
pancreas | 100% | 6547.30 | 328 / 328 | 99% | 38.20 | 177 / 178 |
brain | 99% | 3365.00 | 2628 / 2642 | 100% | 48.33 | 703 / 705 |
intestine | 100% | 4872.97 | 966 / 966 | 99% | 36.69 | 520 / 527 |
prostate | 100% | 4561.56 | 245 / 245 | 98% | 30.92 | 494 / 502 |
adrenal gland | 100% | 5869.28 | 258 / 258 | 98% | 73.98 | 226 / 230 |
stomach | 100% | 4673.21 | 359 / 359 | 98% | 40.34 | 281 / 286 |
thymus | 100% | 6355.34 | 653 / 653 | 98% | 52.56 | 594 / 605 |
breast | 100% | 4677.40 | 459 / 459 | 97% | 33.93 | 1090 / 1118 |
kidney | 100% | 4008.22 | 89 / 89 | 97% | 40.23 | 878 / 901 |
ovary | 100% | 6649.52 | 180 / 180 | 96% | 20.81 | 412 / 430 |
bladder | 100% | 4363.05 | 21 / 21 | 95% | 25.89 | 480 / 504 |
liver | 100% | 4837.87 | 226 / 226 | 93% | 24.96 | 378 / 406 |
skin | 100% | 4029.98 | 1804 / 1809 | 93% | 43.98 | 440 / 472 |
uterus | 100% | 6319.13 | 170 / 170 | 92% | 22.68 | 420 / 459 |
adipose | 100% | 4441.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4382.80 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5845.02 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 2459.89 | 825 / 861 | 0% | 0 | 0 / 0 |
muscle | 95% | 1501.60 | 764 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 14.90 | 38 / 45 |
peripheral blood | 78% | 2851.00 | 720 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 16.59 | 56 / 80 |
lymph node | 0% | 0 | 0 / 0 | 69% | 12.38 | 20 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009566 | Biological process | fertilization |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0060009 | Biological process | Sertoli cell development |
GO_0007286 | Biological process | spermatid development |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000139 | Cellular component | Golgi membrane |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0012506 | Cellular component | vesicle membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0003723 | Molecular function | RNA binding |
Gene name | FNDC3A |
Protein name | Fibronectin type III domain containing 3A Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts) |
Synonyms | hCG_1811703 HUGO KIAA0970 FNDC3 |
Description | FUNCTION: Mediates spermatid-Sertoli adhesion during spermatogenesis. . |
Accessions | ENST00000378383.5 H7C507 ENST00000541916.5 [Q9Y2H6-1] ENST00000398316.7 [Q9Y2H6-2] ENST00000492622.6 [Q9Y2H6-1] A0A087X1M6 Q9Y2H6 ENST00000497644.1 G5E9X3 ENST00000484074.5 |